1 / 4

Dercum’s Disease Market

Dercumu2019s Disease Market Research Report u2013 Forecast to 2023<br>

Rohitravan
Download Presentation

Dercum’s Disease Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Dercum’s Disease Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies), by End-User (Hospital & Clinics, Others)– Forecast Till 2023 Market Highlights The global dercum’s disease market is anticipated to be growing due to factors such increasing expenditures in the healthcare sector in the developed as well as developing economies, growing occurrences of lipomas, increasing prevalence of rare diseases, and rising research and development activities. On the other hand, lack of awareness about the disease is likely to hamper the growth of the market over the forecast period. Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/6350 On the regional basis, the dercum’s disease market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global dercum’s disease market, owing to the owing to the presence of a well- established healthcare segment, and increasing disposable income. Moreover, increasing funding for research and development by government fuels the market growth in this region. The global dercum’s disease market has been segmented into treatment, distribution channel, and end user. Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, F. Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. are some major players in the global dercum’s disease market. Dercum’s disease is a rare pain syndrome characterized by chronically painful growths of fatty tissue or lipomas. These lipomas most commonly occur in the upper arms, upper legs, and trunk region. According to a report by the American Society of Interventional Pain Physicians in 2017, although women are most commonly affected by this condition, about 16% of the reported cases were in men. The common symptoms of this condition include painful fatty lipomas covering the body, obesity majorly in women in menopausal age, weakness, memory issues, elevated heart rate, joint aches, depression, and dementia. Currently, there is no cure for this condition and it is treated symptomatically with surgery, alternative therapies, and with medications such as non-steroidal anti-inflammatory drugs, diuretics, among others. Segmentation The global dercum’s disease market has been segmented into treatment, distribution channel, and end-user. The market, on the basis of treatment, has been segmented into surgery, medication, liposuction, electrotherapy, acupuncture, and others. The medication segment has been further segmented into diuretics, non-steroidal anti-inflammatory drugs, corticosteroids, and others. Market Research Future

  2. The market, by distribution channel, has been segmented into retail pharmacies, hospital pharmacies, and others. The market, by end-user, has been segmented into hospital & clinics, ambulatory surgical centers, and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The dercum’s disease market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European dercum’s disease market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The dercum’s disease market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The dercum’s disease market in the Middle East & Africa has been segmented into the Middle East and Africa. Access Report Details @ https://www.marketresearchfuture.com/reports/dercums-disease- market-6350 The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions. Key players Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, 1.Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc. are some players in the global dercum’s disease market. TOC: 1. Report Prologue 2. Market Introduction 2.1 Definition 2.2 Scope of the Study Market Research Future

  3. 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 3. Research Methodology 3.1 Introduction 3.2 Primary Research 3.3 Secondary research 3.4 Market Size Estimation TOC…Continued Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/6350 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Market Research Future

  4. Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com Market Research Future

More Related